1.) How many adult severe asthma patients have been seen via both in-patient visits and outpatient clinics in the last 3 months?
2.) How many adult severe asthma patients have you treated with a biologic in the last 3 months?
3.) Of these patients treated, can you provide which drugs they were treated with, as follows:
• Omalizumab (Xolair)
• Mepolizumab (Nucala)
• Resilizumab (Cinqaero)

Download response letter Severe Asthma patients. 311017